Li RY - Search Results

1

Screening and identification of permeable components in a combined prescription of Danggui Buxue decoction using a liposome equilibrium dialysis system followed by HPLC and LC-MS.

Qi LW, Li P, Li SL, Sheng LH, Li RY, Song Y, Li HJ. Qi LW, et al. Among authors: li hj, li ry, li sl, li p. J Sep Sci. 2006 Sep;29(14):2211-20. doi: 10.1002/jssc.200600107. J Sep Sci. 2006. PMID: 17069252

2

Live cell extraction and HPLC-MS analysis for predicting bioactive components of traditional Chinese medicines.

Li SL, Li P, Sheng LH, Li RY, Qi LW, Zhang LY. Li SL, et al. Among authors: li ry, li p. J Pharm Biomed Anal. 2006 May 3;41(2):576-81. doi: 10.1016/j.jpba.2006.01.014. Epub 2006 Feb 20. J Pharm Biomed Anal. 2006. PMID: 16488100

3

Gegen Qinlian decoction alleviates experimental colitis via suppressing TLR4/NF-κB signaling and enhancing antioxidant effect.

Li R, Chen Y, Shi M, Xu X, Zhao Y, Wu X, Zhang Y. Li R, et al. Phytomedicine. 2016 Sep 15;23(10):1012-20. doi: 10.1016/j.phymed.2016.06.010. Epub 2016 Jun 15. Phytomedicine. 2016. PMID: 27444346

4

Gegen Qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17/Treg cell homeostasis via suppressing IL-6/JAK2/STAT3 signaling.

Zhao Y, Luan H, Jiang H, Xu Y, Wu X, Zhang Y, Li R. Zhao Y, et al. Phytomedicine. 2021 Apr;84:153519. doi: 10.1016/j.phymed.2021.153519. Epub 2021 Feb 18. Phytomedicine. 2021. PMID: 33640781

5

Gegen Qinlian decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling.

Zhao Y, Luan H, Gao H, Wu X, Zhang Y, Li R. Zhao Y, et al. Phytomedicine. 2020 Mar;68:153182. doi: 10.1016/j.phymed.2020.153182. Epub 2020 Feb 7. Phytomedicine. 2020. PMID: 32065953

6

Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-κB signaling and T-helper cell homeostasis.

Chen YY, Li RY, Shi MJ, Zhao YX, Yan Y, Xu XX, Zhang M, Zhao XT, Zhang YB. Chen YY, et al. Among authors: li ry. Inflamm Res. 2017 Feb;66(2):187-196. doi: 10.1007/s00011-016-1005-3. Epub 2016 Nov 29. Inflamm Res. 2017. PMID: 27900412

7

Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model.

Zhang P, Qiang X, Zhang M, Ma D, Zhao Z, Zhou C, Liu X, Li R, Chen H, Zhang Y. Zhang P, et al. J Pharmacol Exp Ther. 2015 Jan;352(1):139-47. doi: 10.1124/jpet.114.219832. Epub 2014 Oct 31. J Pharmacol Exp Ther. 2015. PMID: 25362106

8

Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice.

Zhang Y, Wen J, Liu D, Qiu Z, Zhu Q, Li R, Zhang Y. Zhang Y, et al. Life Sci. 2021 Sep 15;281:119778. doi: 10.1016/j.lfs.2021.119778. Epub 2021 Jun 27. Life Sci. 2021. PMID: 34192596

9

Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis.

Xu L, Zheng X, Wang Y, Fan Q, Zhang M, Li R, Ye J, Wu X, Zhao W, Zhang Y. Xu L, et al. Eur J Pharmacol. 2018 Jan 15;819:161-168. doi: 10.1016/j.ejphar.2017.11.013. Epub 2017 Nov 27. Eur J Pharmacol. 2018. PMID: 29191769

10

Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling.

Zhang M, Li Q, Zhou C, Zhao Y, Li R, Zhang Y. Zhang M, et al. Int Immunopharmacol. 2020 Mar;80:106137. doi: 10.1016/j.intimp.2019.106137. Epub 2020 Jan 10. Int Immunopharmacol. 2020. PMID: 31931366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

420 results

Search Page

Filters